ANGPTL4 and cholangiocarcinoma: The results showed that serum ANGPTL4 level in CCA patients (0.6017 ± 0.3767 AU) was significantly higher than that of healthy controls (0.1634 ± 0.1739 AU, p < 0.0001) (Figure 3A).